Literature DB >> 31111428

Plasma Replacement Therapy for Alzheimer's Disease.

Xu-Long Ding1,2,3, Peng Lei4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31111428      PMCID： PMC6940398          DOI： 10.1007/s12264-019-00394-5

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  2 in total

Review 1.  Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.

Authors:  Yuan Cheng; Ding-Yuan Tian; Yan-Jiang Wang
Journal:  Transl Neurodegener       Date:  2020-05-07       Impact factor: 8.014

2.  Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.

Authors:  Wenting Hu; Zhuoqun Wang; Huiliang Zhang; Yacoubou Abdoul Razak Mahaman; Fang Huang; Dongli Meng; Ying Zhou; Shiyi Wang; Nan Jiang; Jing Xiong; Jukka Westermarck; Youming Lu; Jianzhi Wang; Xiaochuan Wang; Yangping Shentu; Rong Liu
Journal:  Neurotherapeutics       Date:  2022-03-14       Impact factor: 6.088
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.